Free Trial

InMode (INMD) Stock Price, News & Analysis

InMode logo
$15.59 -0.42 (-2.62%)
Closing price 10/22/2025 04:00 PM Eastern
Extended Trading
$15.80 +0.22 (+1.38%)
As of 10/22/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About InMode Stock (NASDAQ:INMD)

Advanced

Key Stats

Today's Range
$15.51
$16.07
50-Day Range
$14.18
$16.01
52-Week Range
$13.14
$19.85
Volume
510,801 shs
Average Volume
788,962 shs
Market Capitalization
$985.44 million
P/E Ratio
6.31
Dividend Yield
N/A
Price Target
$16.85
Consensus Rating
Hold

Company Overview

InMode Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

INMD MarketRank™: 

InMode scored higher than 59% of companies evaluated by MarketBeat, and ranked 420th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InMode has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 8 hold ratings, and 1 sell rating.

  • Upside/Downside

    The consensus price target for InMode is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    InMode has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about InMode's stock forecast and price target.
  • Earnings Growth

    Earnings for InMode are expected to grow by 4.00% in the coming year, from $1.75 to $1.82 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InMode is 6.31, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 79.37.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InMode is 6.31, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.09.

  • Price to Book Value per Share Ratio

    InMode has a P/B Ratio of 1.54. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about InMode's valuation and earnings.
  • Percentage of Shares Shorted

    4.76% of the outstanding shares of InMode have been sold short.
  • Short Interest Ratio / Days to Cover

    InMode has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InMode has recently decreased by 14.25%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    InMode does not currently pay a dividend.

  • Dividend Growth

    InMode does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.76% of the outstanding shares of InMode have been sold short.
  • Short Interest Ratio / Days to Cover

    InMode has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InMode has recently decreased by 14.25%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    InMode has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for InMode this week, compared to 5 articles on an average week.
  • Search Interest

    Only 1 people have searched for INMD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added InMode to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InMode insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.92% of the stock of InMode is held by insiders.

  • Percentage Held by Institutions

    68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about InMode's insider trading history.
Receive INMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INMD Stock News Headlines

InMode (NASDAQ:INMD) Upgraded at Wall Street Zen
NEW LAW: Congress Approves Setup For Digital Dollar?
Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor Green, it's a bill that contains "the entire setup, groundwork and infrastructure to move from cash to digital currency."tc pixel
InMode (NASDAQ:INMD) Price Target Raised to $16.00
See More Headlines

INMD Stock Analysis - Frequently Asked Questions

InMode's stock was trading at $16.70 at the start of the year. Since then, INMD shares have decreased by 6.6% and is now trading at $15.59.

InMode Ltd. (NASDAQ:INMD) released its quarterly earnings data on Wednesday, July, 30th. The healthcare company reported $0.47 EPS for the quarter, missing the consensus estimate of $0.50 by $0.03. InMode's quarterly revenue was up 10.6% on a year-over-year basis.
Read the conference call transcript
.

InMode shares split before market open on Thursday, September 30th 2021.The 2-1 split was announced on Friday, September 17th 2021. The newly minted shares were issued to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

InMode subsidiaries include Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd..

InMode (INMD) raised $75 million in an initial public offering (IPO) on Thursday, August 8th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. ​Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager.

Top institutional shareholders of InMode include North Growth Management Ltd. (1.03%), Lind Value II ApS (0.28%), Taylor Frigon Capital Management LLC (0.15%) and CWA Asset Management Group LLC (0.15%).

Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/30/2025
Today
10/23/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:INMD
CIK
1742692
Fax
N/A
Employees
480
Year Founded
2008

Price Target and Rating

High Price Target
$21.00
Low Price Target
$15.00
Potential Upside/Downside
+8.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.47
Trailing P/E Ratio
6.31
Forward P/E Ratio
8.91
P/E Growth
N/A
Net Income
$181.27 million
Net Margins
44.50%
Pretax Margin
35.81%
Return on Equity
18.38%
Return on Assets
16.35%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.60
Quick Ratio
8.58

Sales & Book Value

Annual Sales
$394.82 million
Price / Sales
2.50
Cash Flow
$1.78 per share
Price / Cash Flow
8.78
Book Value
$10.12 per share
Price / Book
1.54

Miscellaneous

Outstanding Shares
63,210,000
Free Float
58,835,000
Market Cap
$985.44 million
Optionable
Optionable
Beta
2.09

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:INMD) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners